Literature DB >> 25049046

Canakinumab for the treatment of children with colchicine-resistant familial Mediterranean fever: a 6-month open-label, single-arm pilot study.

Riva Brik1, Yonatan Butbul-Aviel, Sari Lubin, Eliad Ben Dayan, Tamar Rachmilewitz-Minei, Lillian Tseng, Philip J Hashkes.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25049046     DOI: 10.1002/art.38777

Source DB:  PubMed          Journal:  Arthritis Rheumatol        ISSN: 2326-5191            Impact factor:   10.995


× No keyword cloud information.
  24 in total

Review 1.  Efficacy and safety of treatments in Familial Mediterranean fever: a systematic review.

Authors:  Erkan Demirkaya; Burak Erer; Seza Ozen; Eldad Ben-Chetrit
Journal:  Rheumatol Int       Date:  2015-12-19       Impact factor: 2.631

Review 2.  The myths we believed in familial Mediterranean fever: what have we learned in the past years?

Authors:  Seza Ozen; Ezgi Deniz Batu
Journal:  Semin Immunopathol       Date:  2015-04-02       Impact factor: 9.623

3.  Canakinumab in Children with Familial Mediterranean Fever: A Single-Center, Retrospective Analysis.

Authors:  Rabia Miray Kisla Ekinci; Sibel Balci; Dilek Dogruel; Derya Ufuk Altintas; Mustafa Yilmaz
Journal:  Paediatr Drugs       Date:  2019-10       Impact factor: 3.022

Review 4.  Familial Mediterranean fever, review of the literature.

Authors:  Mansour Alghamdi
Journal:  Clin Rheumatol       Date:  2017-06-18       Impact factor: 2.980

Review 5.  Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies.

Authors:  Joshua S Davis; David Ferreira; Emma Paige; Craig Gedye; Michael Boyle
Journal:  Clin Microbiol Rev       Date:  2020-06-10       Impact factor: 26.132

Review 6.  Successful management of colchicine resistant familial Mediterranean fever patients with a standardized canakinumab treatment protocol: a case series and literature review.

Authors:  Sanem Eren Akarcan; Seyda Dogantan; Neslihan Edeer Karaca; Guzide Aksu; Necil Kutukculer
Journal:  Rheumatol Int       Date:  2019-07-04       Impact factor: 2.631

Review 7.  Interventions for reducing inflammation in familial Mediterranean fever.

Authors:  Xi Yin; Fangyuan Tian; Bin Wu; Ting Xu
Journal:  Cochrane Database Syst Rev       Date:  2022-03-29

8.  Canakinumab treatment in children with familial Mediterranean fever: report from a single center.

Authors:  Fatma Yazılıtaş; Özlem Aydoğ; Sare Gülfem Özlü; Evrim Kargın Çakıcı; Tülin Güngör; Fehime Kara Eroğlu; Gökçe Gür; Mehmet Bülbül
Journal:  Rheumatol Int       Date:  2018-02-15       Impact factor: 2.631

Review 9.  Monogenic Autoinflammatory Diseases: State of the Art and Future Perspectives.

Authors:  Giulia Di Donato; Debora Mariarita d'Angelo; Luciana Breda; Francesco Chiarelli
Journal:  Int J Mol Sci       Date:  2021-06-14       Impact factor: 5.923

10.  Interventions for reducing inflammation in familial Mediterranean fever.

Authors:  Bin Wu; Ting Xu; Youping Li; Xi Yin
Journal:  Cochrane Database Syst Rev       Date:  2018-10-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.